ICU Medical, Inc. (NASDAQ:ICUI) Shares Acquired by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC grew its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 9.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,673 shares of the medical instruments supplier’s stock after purchasing an additional 308 shares during the period. Mutual of America Capital Management LLC’s holdings in ICU Medical were worth $669,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Innealta Capital LLC purchased a new position in ICU Medical during the second quarter valued at $32,000. Hexagon Capital Partners LLC raised its position in shares of ICU Medical by 162.7% during the 3rd quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 122 shares during the last quarter. Allworth Financial LP lifted its stake in ICU Medical by 100.0% in the 3rd quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 100 shares in the last quarter. Russell Investments Group Ltd. boosted its holdings in ICU Medical by 46.4% in the 1st quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier’s stock worth $59,000 after buying an additional 173 shares during the last quarter. Finally, Venturi Wealth Management LLC increased its stake in ICU Medical by 1,510.0% during the 3rd quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock worth $59,000 after buying an additional 302 shares in the last quarter. 96.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. KeyCorp upped their target price on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a report on Wednesday, November 13th. Raymond James increased their price objective on shares of ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a report on Thursday, September 12th. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. Jefferies Financial Group began coverage on ICU Medical in a research report on Monday, October 14th. They issued a “hold” rating and a $183.00 price target for the company. Finally, StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, ICU Medical has an average rating of “Moderate Buy” and an average price target of $173.00.

ICU Medical Stock Down 6.0 %

Shares of ICU Medical stock opened at $157.75 on Wednesday. ICU Medical, Inc. has a one year low of $83.26 and a one year high of $196.26. The company has a market cap of $3.86 billion, a P/E ratio of -34.68 and a beta of 0.66. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The firm has a fifty day moving average of $175.98 and a two-hundred day moving average of $146.15.

Insider Activity at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $178.46, for a total value of $2,141,520.00. Following the transaction, the chief executive officer now owns 104,593 shares in the company, valued at $18,665,666.78. This trade represents a 10.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Daniel Woolson sold 2,502 shares of ICU Medical stock in a transaction on Friday, August 30th. The shares were sold at an average price of $163.22, for a total value of $408,376.44. Following the completion of the transaction, the vice president now owns 13,107 shares in the company, valued at $2,139,324.54. The trade was a 16.03 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 40,464 shares of company stock valued at $6,905,231 in the last ninety days. Corporate insiders own 6.70% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.